Focus

bebtelovimab

Companies
Companies

FDA Pulls Authorization for Eli Lilly’s COVID-19 Drug Bebtelovimab

FDA Pulls Authorization for Eli Lilly’s COVID-19 Drug Bebtelovimab
|